Indraprastha Medical Corporation Limited
NSE: INDRAMEDCO BSE: INDRAMEDCO
Prev Close
477.15
Open Price
472.75
Volume
135,220
Today Low / High
464.4 / 480.15
52 WK Low / High
250.35 / 572
Range
447 - 494
Prev Close
477.15
Open Price
466.7
Volume
22,745
Today Low / High
464.7 / 480
52 WK Low / High
238.05 / 571.95
Range
447 - 494
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 470 (target range: 447 - 494), reflecting a change of -7.15 (-1.49848%). On the BSE, it is listed at 470.3 (target range: 447 - 494), showing a change of -6.85 (-1.43561%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
Indraprastha Medical Corporation Limited Graph
Indraprastha Medical Corporation Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Indraprastha Medical Corporation Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 470.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 470.30 | 475.00 | 427.50 - 522.50 |
| 479.71 | 383.76 - 575.65 | ||
| 484.41 | 339.09 - 629.73 | ||
| Bearish Scenario | 470.30 | 465.60 | 419.04 - 512.16 |
| 460.89 | 368.72 - 553.07 | ||
| 456.19 | 319.33 - 593.05 |
Overview of Indraprastha Medical Corporation Limited
ISIN
INE681B01017
Industry
Medical - Care Facilities
Vol.Avg
267,961
Market Cap
43,741,771,950
Last Dividend
4.5
Official Website
IPO Date
1997-05-07
DCF Diff
-214.89
DCF
692
Financial Ratios Every Investor Needs
Stock Dividend of INDRAMEDCO
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-09-13 | September 13, 24 | 4.5 | 4.5 | 2024-09-13 | 2024-10-24 | |
| 2023-09-15 | September 15, 23 | 3 | 3 | 2023-09-15 | 2023-10-21 | |
| 2022-09-15 | September 15, 22 | 2.5 | 2.5 | 2022-09-16 | 2022-10-23 | |
| 2019-09-12 | September 12, 19 | 1.6 | 1.6 | 2019-09-13 | 2019-10-30 | 2019-05-08 |
| 2018-09-12 | September 12, 18 | 1.5 | 1.5 | 2018-09-14 | 2018-10-30 | 2018-05-09 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,356.36 Cr | 862.74 Cr | 493.62 Cr | 0.3639 | 0.00 Cr | 0.00 Cr | 493.62 Cr | 160.99 Cr | 17.56 | 244.27 Cr | 0.1187 |
| 2024-03-31 | 1,244.70 Cr | 790.59 Cr | 454.11 Cr | 0.3648 | 0.00 Cr | 11.75 Cr | 155.69 Cr | 123.96 Cr | 13.52 | 207.25 Cr | 0.0996 |
| 2023-03-31 | 1,098.67 Cr | 474.16 Cr | 624.51 Cr | 0.5684 | 0.00 Cr | 9.69 Cr | 112.30 Cr | 86.15 Cr | 9.40 | 160.73 Cr | 0.0784 |
| 2022-03-31 | 862.14 Cr | 383.24 Cr | 478.90 Cr | 0.5555 | 0.00 Cr | 6.86 Cr | 85.13 Cr | 58.62 Cr | 6.39 | 117.42 Cr | 0.0680 |
| 2021-03-31 | 596.04 Cr | 248.86 Cr | 347.18 Cr | 0.5825 | 0.00 Cr | 5.65 Cr | 7.66 Cr | 2.33 Cr | 0.25 | 40.95 Cr | 0.0039 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 321.75 Cr | 851.62 Cr | 254.94 Cr | 596.6800 Cr | 32.76 Cr | -288.99 Cr | 6.99 Cr | 359.99 Cr | 0.00 Cr | 0.00 Cr | 57.12 Cr | 178.7100 Cr |
| 2024-03-31 | 61.60 Cr | 723.24 Cr | 245.48 Cr | 477.7600 Cr | 33.95 Cr | -27.65 Cr | 7.53 Cr | 346.36 Cr | 8.80 Cr | 0.00 Cr | -104.04 Cr | 165.4200 Cr |
| 2023-03-31 | 52.26 Cr | 555.14 Cr | 175.69 Cr | 379.4500 Cr | 2.48 Cr | -49.78 Cr | 8.45 Cr | 276.62 Cr | 14.67 Cr | 0.00 Cr | 45.51 Cr | 129.6300 Cr |
| 2022-03-31 | 41.74 Cr | 461.71 Cr | 136.27 Cr | 325.4400 Cr | 5.31 Cr | -36.43 Cr | 9.99 Cr | 275.15 Cr | 9.79 Cr | 0.00 Cr | 23.01 Cr | 93.5000 Cr |
| 2021-03-31 | 24.92 Cr | 431.96 Cr | 159.20 Cr | 272.7560 Cr | 7.82 Cr | -17.10 Cr | 8.74 Cr | 283.29 Cr | 16.14 Cr | 0.00 Cr | -5.69 Cr | 115.9060 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 156.7500 Cr | -110.9900 Cr | -45.8800 Cr | 120.4200 Cr | -0.1200 Cr | 61.4800 Cr | -36.3300 Cr | 160.9900 Cr | -2.1300 Cr | -40.7300 Cr | 0.5400 Cr |
| 2024-03-31 | 200.1500 Cr | -158.4300 Cr | -32.3800 Cr | 130.7600 Cr | 9.3400 Cr | 61.6000 Cr | -69.3900 Cr | 123.9600 Cr | 0.0000 Cr | -27.5400 Cr | 0.9200 Cr |
| 2023-03-31 | 144.4700 Cr | -107.9100 Cr | -26.0400 Cr | 99.8900 Cr | 10.5200 Cr | 52.2600 Cr | -44.5800 Cr | 117.1800 Cr | -2.8300 Cr | -22.8400 Cr | 1.5400 Cr |
| 2022-03-31 | 71.2900 Cr | -51.1000 Cr | -3.3700 Cr | 41.8100 Cr | 16.8200 Cr | 41.7400 Cr | -29.4800 Cr | 79.0700 Cr | -2.5100 Cr | -0.2600 Cr | -1.2500 Cr |
| 2021-03-31 | 27.8980 Cr | -20.1620 Cr | -3.1470 Cr | 6.9350 Cr | 4.5890 Cr | 24.9210 Cr | -20.9630 Cr | 4.2890 Cr | -2.0900 Cr | -0.2450 Cr | 3.3270 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 333.75 Cr | 213.15 Cr | 120.60 Cr | 0.3613 | 120.60 Cr | 41.01 Cr | 4.47 | 61.49 Cr | 0.1229 |
| 2024-12-31 | 324.93 Cr | 214.40 Cr | 110.53 Cr | 0.3402 | 40.98 Cr | 32.81 Cr | 3.58 | 57.32 Cr | 0.1010 |
| 2024-09-30 | 349.82 Cr | 230.17 Cr | 119.65 Cr | 0.3420 | 52.47 Cr | 42.40 Cr | 4.63 | 69.69 Cr | 0.1212 |
| 2024-06-30 | 347.86 Cr | 227.23 Cr | 120.63 Cr | 0.3468 | 56.08 Cr | 44.77 Cr | 4.88 | 72.24 Cr | 0.1287 |
| 2024-03-31 | 314.73 Cr | 210.66 Cr | 104.07 Cr | 0.3307 | 38.23 Cr | 31.17 Cr | 3.40 | 53.33 Cr | 0.0990 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 321.75 Cr | 0.00 Cr | 321.75 Cr | 75.45 Cr | 6.99 Cr | 431.13 Cr | 359.99 Cr | 851.62 Cr | 254.94 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 309.35 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -524.43 Cr |
| 2024-09-30 | 66.77 Cr | 242.58 Cr | 309.35 Cr | 75.14 Cr | 7.86 Cr | 419.66 Cr | 340.79 Cr | 806.32 Cr | 281.89 Cr |
| 2024-06-30 | -224.43 Cr | 448.86 Cr | 224.43 Cr | 0.00 Cr | 0.00 Cr | 224.43 Cr | 0.00 Cr | 0.00 Cr | -477.76 Cr |
| 2024-03-31 | 224.43 Cr | 169.30 Cr | 224.43 Cr | 64.26 Cr | 7.53 Cr | 307.98 Cr | 346.36 Cr | 723.24 Cr | 245.48 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 41.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 32.81 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 42.40 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 44.77 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 31.17 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,246.00 | ₹1,211,295,162,000.00 | ₹2,265,585.00 |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,498.00 | ₹1,078,099,930,000.00 | ₹342,578.00 |
| Fortis Healthcare Limited | FORTIS | ₹857.45 | ₹647,338,737,100.00 | ₹2,038,830.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,915.20 | ₹391,392,187,200.00 | ₹408,287.00 |
| Global Health Limited | MEDANTA | ₹1,311.20 | ₹352,267,477,144.00 | ₹106,587.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹604.90 | ₹313,411,392,900.00 | ₹2,687,054.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹751.20 | ₹300,584,416,800.00 | ₹257,184.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,524.40 | ₹154,805,371,846.00 | ₹100,309.00 |
| HealthCare Global Enterprises Limited | HCG | ₹622.05 | ₹86,723,100,750.00 | ₹259,467.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹643.95 | ₹62,047,386,902.00 | ₹611,906.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹470.00 | ₹43,086,310,000.00 | ₹135,220.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹239.05 | ₹33,204,045,000.00 | ₹58,464.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born: 1972
Gender: male
Year Born: 1966
FAQs about Indraprastha Medical Corporation Limited
The CEO is Shivakumar Pattabhiraman ACA, B Com, CWA,.
The current price is ₹477.15.
The range is ₹250.35-572.
The market capitalization is ₹4,374.18 crores.
The dividend yield is 0.94%.
The P/E ratio is 27.19.
The company operates in the Healthcare sector.
Overview of Indraprastha Medical Corporation Limited (ISIN: INE681B01017) is a leading Medical - Care Facilities in India. With a market capitalization of ₹4,374.18 crores and an average daily volume of 267,961 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹4.5.